[Actinic keratoses].
Actinic keratosis (AK) is a very common skin diagnosis in office-based dermatology. Due to the demographic changes with increasing numbers of elderly people, the proportion of patients with AK is expected rise. In order to avoid progression into squamous cell carcinoma, early treatment is recommended. Numerous treatment options are currently available for this purpose. In addition to targeted therapies for isolated AK many field-directed treatment modalities are available. However, the treatment option that is finally chosen depends on a variety of factors (e.g., age of the patient, the extent of the clinical findings) and the patient's needs and therefore has to be customized.
Behandlungszentrum Knappschaftskrankenhaus Recklinghausen, Klinik für Dermatologie und Allergologie, Klinikum VEST GmbH, Dorstener Str. 151, 45657, Recklinghausen, Deutschland. theresa.hommel@klinikum-vest.de.
T
T
Hommel
Behandlungszentrum Knappschaftskrankenhaus Recklinghausen, Klinik für Dermatologie und Allergologie, Klinikum VEST GmbH, Dorstener Str. 151, 45657, Recklinghausen, Deutschland.
R-M
RM
Szeimies
D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000473:pathology* / Q000517:prevention & control*; D003131:Combined Modality Therapy / Q000379:methods; D062109:Dermatologic Surgical Procedures / Q000379:methods; D019317:Evidence-Based Medicine; D006801:Humans; D055623:Keratosis, Actinic / Q000175:diagnosis / Q000473:pathology* / Q000628:therapy*; D058990:Molecular Targeted Therapy / Q000379:methods; D010778:Photochemotherapy / Q000379:methods; D012878:Skin Neoplasms / Q000175:diagnosis / Q000473:pathology* / Q000517:prevention & control*; D016896:Treatment Outcome
Field-directed treatment; Keratinocytes; Lesions; Precancerous conditions; Squamous cell carcinoma